1[1]Kinoshita J,Kitamura K,Kabashima A et al.Clinical significance of vascular endothelial growth factor-C(VEGF-C) in breast cancer.Breast Cancer Res Treat,2001,66:159
2[2]Spigel DR,Burstein HJ.HER2 overexpressing metastatic breast cancer.Curr Treat Options Oncol,2002,3:163
3[3]Camp RL,Rimm EB,Rimm DL.Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.Cancer,1999,86:2259
4LI Qiu li, CHEN Fu jingDepartment of Head &Neck,Cancer Center,Sun Yat sen University,Guangzhou 510060,P.R.China.血管内皮生长因子-C、-D与肿瘤淋巴道转移研究进展[J].癌症,2002,21(6):696-700. 被引量：22
5[5]Jeltsch M,Kaipainen A,Joukov V et al.Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.Science,1997,276:1423
6[6]Mandriota SJ,Jussila L,Jeltsch M et al.Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumor metastasis.EMBO,2001,20:672
7[7]Yonemura Y,Endo Y,Fujita H et al.Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer.Clin Cancer Res,1999,5:1823
8[8]Kurebayashi J,Otsuki T,Kunisue H et al.Expression of vascular endothelial growth factor (VEGF)family members in breast cancer.Jpn J Cancer Res,1999,90:977
9[9]Jussila L,Alitalo K.Vascular growth factors and lymphangiogenesis.Physiol Rev,2002,82:673
10[10]Furudoi A,Tanaka S,Kitadai Y et al.Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.Oncology,2002,62:157
二级参考文献39
1Cao Y, Linden P, Farnebo J, Cao R, et al. Vascular endothelial growth factor C induces angiogenesis in vivo [J]. Proc Natl Acad Sci U S A, 1998, 95(24):14389-14394.
2Hofmann M, Rudy W, Zoller M, et al. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumour cell line [J]. Cancer Res, 1991, 51:5292-5297.
3Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis [J]. Br J Cancer, 1999, 80(1-2):309-313.
4Lymboussaki A, Olofsson B, Eriksson U, et al. Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia [J]. Circ Res, 1999,85(11):992-999.
5Roselle J, Eisma BS, Jeffrey D, et al. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma [J]. Am J Surg, 1997, 174: 513-517.
6Dray TG, Hardin NJ, Sofferman RA, et al. Angiogenesis as a prognostic marker in early head and neck cancer [J]. Ann Otol Rhiol Laryngol, 1995; 104:724-729.
7Ari Ristim, Kirsi Narko, Berndt Enholm, et al. Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-C [J]. J Biol Chem, 1998, 273:8413-8418.
8Berger DP, Herbstritt L, Dengler WA, et al. Vascular endothelial growth factor (VEGF) mRNA expression in human tumor models of different histologies [J]. Ann Oncol, 1995, 6: 817-825.
9Joukov V, Kumar V, Sorsa T, et al. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities [J]. J Bio Chem, 1998, 273(12):6599-6602.
10Oh SJ, Jeltsch MM, Birkenhager R, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane [J]. Dev Biol, 1997,188(1):96-109.
1Chhieng DC, Tabbara SO, Marley EF, et al. Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma[ J]. Breast J,2003 ,9(3) :200-207.
2Toi M, Inada K, Suzuki H, et al. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression [ J ]. Breast Cancer Res Treat, 1995,36:193-204.
3Gasparini G, Toi M, Gion M ,et al. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma[ J]. J Natl Cancer Inst, 1997,89:139-147.
4Linderholm BK, Lindh B, Beckman L, et al. Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers[ J]. Clin Breast Cancer,2003,4(5): 340-347.
5De Falco S, Gigante B, Persico MG. Structure and function of placental growth factor [ J ]. Trends Gardiovasc Med, 2002 , 12 (6):241-246.
6Gunningham SP, Currie M J, Han C, et al. VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis [ J ]. J Pathol,2001,193 ( 3 ) :325-332.
7Kurebayashi J, Otsuki T, Kunisue H, et al. Expression of vascular endothelial growth factor (VEGF)family members in breast cancer[J] . Jpn J Cancer Res, 1999,90:977.
8Salven P, Lymboussaki A, Heikkila P, et al. Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expression in Human Tumors[J]. Am J Pathol, 1998,153(1) :103-108.
9Valtola R, Salven P, Heikkila P, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer[ J]. Am J Pathol, 1999,154 ( 5 ): 1381-1390.
10Kinoshita J, Kitamura K, Kabashima A, et al. Clinical significance of vascular endothelial growth factor-C (VEGF-C) in breast cancer[J]. Breast Cancer Res Treat, 2001,66(2) :159-164.
